HUBACEK, J. A., T. PHILIPP, V. ADAMKOVA, Ondřej MÁJEK a Ladislav DUŠEK. A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population. Clinica Chimica Acta. AMSTERDAM: ELSEVIER SCIENCE BV, 2023, roč. 538, January 2023, s. 211-215. ISSN 0009-8981. Dostupné z: https://dx.doi.org/10.1016/j.cca.2022.12.025.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population
Autoři HUBACEK, J. A. (203 Česká republika, garant), T. PHILIPP (203 Česká republika), V. ADAMKOVA (203 Česká republika), Ondřej MÁJEK (203 Česká republika, domácí) a Ladislav DUŠEK (203 Česká republika, domácí).
Vydání Clinica Chimica Acta, AMSTERDAM, ELSEVIER SCIENCE BV, 2023, 0009-8981.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30230 Other clinical medicine subjects
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.000 v roce 2022
Kód RIV RIV/00216224:14110/23:00130381
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.cca.2022.12.025
UT WoS 000923428500001
Klíčová slova anglicky COVID-19; HFE; Iron; Polymorphism; Susceptibility
Štítky 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 28. 2. 2023 08:21.
Anotace
Background: Coronavirus disease (COVID-19), which is caused by the SARS-CoV-2 virus, has become a global pandemic. While susceptibility to COVID-19 is subject to several external factors, including hypertension, BMI, and the presence of diabetes, it is also genetically determined to a significant extent. Infectious agents require iron (Fe) for proper functioning. Carriers of mutations resulting in increased iron concentrations are understood to be at increased risk of COVID-19.Methods: We examined HFE genotypes associated with hereditary haemochromatosis (rs1800562 and rs1799945 SNPs) in 617 COVID-19 patients (166 asymptomatic, 246 symptomatic and 205 hospitalised survivors) and 2 559 population-based controls.Results: We found a higher frequency of the minor allele (Tyr282) of the rs1800562 polymorphism (P < 0.002) in patients compared to controls (8.5 % vs 5.5 %). Non-carriers of the minor allele were protected against SARS-Cov-2 infection (OR, 95 %CI; 0.59, 0.42-0.82). The frequency of minor allele carriers was almost identical across asymptomatic, symptomatic, and hospitalised survivors. The rs1799945 variant did not affect disease severity and its occurrence was almost identical in patients and controls (P between 0.58 and 0.84).Conclusions: In conclusion, our results indicate that presence of the rs1800562 minor allele, which is associated with hereditary haemochromatosis (thus increased levels of plasma Fe), increases susceptibility to SARS-CoV-2.
VytisknoutZobrazeno: 13. 5. 2024 21:52